By signing the Copyright Letter, the authors retain the rights of self-archiving (subject to certain restrictions).
Following are the important features of the self-archiving policy of Bentham Science journals:
Authors can deposit the first draft of a submitted article on their personal websites or their institution’s repositories for personal use, internal institutional use, or for permitted scholarly posting only.
Authors may deposit the ACCEPTED VERSION of the peer-reviewed article on their personal websites, their institution’s repository or the non-commercial repositories, PMC and arXiv, after 12 MONTHS of publication on the journal website. For personal use, internal institutional use, or for permitted scholarly posting only.
In case of (b) above, an acknowledgement must be given to the original source of publication and a link must be inserted to the published article on the journal's/publisher’s website. The link to the original source of publication should be provided by inserting the DOI number of the article in the following sentence: “The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/[insert DOI].”
If the research is funded by NIH, Wellcome Trust or any other Open Access Mandate, authors are allowed the archiving of published versions of manuscripts in the nominated institutional repositories, after the mandatory embargo period. Authors should first contact the Editorial Office of the journal for information about depositing a copy of the manuscript to a repository. Consistent with the copyright agreement, Bentham Science does not allow archiving of FINAL PUBLISHED VERSION of manuscripts unless under an Open Access mandate as above. Archiving, under any of the above mentioned Open Access mandates, is done under the terms of the Creative Commons License CC BY-NC-ND 4.0 - Attribution-NonCommercial-NoDerivatives 4.0 International.
There is no embargo on the archiving of articles published under the OPEN ACCESS PLUS category. Authors are allowed deposition of such articles on institutional, non-commercial repositories and personal websites immediately after publication on the journal website. This is done under the terms of the Creative Commons Attribution 4.0 International Public License CC-BY 4.0.
In case of any form of archiving, an acknowledgement must be given to the original source of publication and a link must be inserted to the published article on the journal's/publisher’s website. The link to the original source of publication should be provided by inserting the DOI number of the article in the following sentence: “The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/[insert DOI].”
LONG-TERM ARCHIVING OF BENTHAM SCIENCE CONTENT
To ensure permanent access to our publications, Bentham Science has an agreement with Portico to have a long-term preservation of the content published in its journals.
Syed A.A. Rizvi College of Biomedical Sciences Larkin University Miami, Florida (United States) Biography
Biography of Syed A.A. Rizvi
Syed A.A. Rizvi is a Professor of Pharmaceutical and Biomedical Sciences and a broadly trained scientist, educator, and healthcare contributor with vast clinical and translational research experience, driving innovation within pharmaceutical product development platforms. He is highly motivated and committed to advancing medical innovation and education, discovering new therapies, improving patient outcomes, and playing an instrumental role in scientific and business strategies. Dr. Rizvi has extensive training and background spanning over 25 years of experience in industrial, academic, administration, and healthcare settings.
He has published over 200 peer-reviewed articles, including journal publications, book chapters, books, US patents, and oral/poster presentations. His publications include highly rated articles and cover articles. He also serves on the editorial boards/panels of different journals in various capacities and reviews manuscripts and books for over 150 well-known scientific journals and books. Dr. Rizvi enjoys teaching, cooking, and practicing martial arts (Hakko-Ryu Jujutsu and black belt in Okinawan Goju Ryu Karate).
His research interests incorporate clinical and translational research including clinical trials, graduate medical education (GME) pharmaceutical formulations (direct compressed tablets, topicals and liquids); ionic liquid formation and cocrystallization of the pharmaceutical compounds; nano and micro-encapsulation of the drugs for targeting and controlled release; multistep synthesis of small organic molecules; pharmaceutical analysis (forensics and method development); design and synthesis of novel monomeric and polymeric surfactants for separation of chiral and achiral compounds in micellar electrokinetic chromatography (MEKC); method development and validation for separations of achiral and chiral compounds utilizing MEKC-UV/MS and HPLC-UV-MS; application of cryogenic high resolution scanning electron microscopy (Cryo-HRSEM) and analytical ultracentrifuge for characterization of polymeric surfactants; chemical transformation of pharmacologically active compounds using microbial whole cultures; isolation and pharmacology of compounds from fungal metabolites and medicinal plants; fragrance and aroma chemistry; Cosmeceutical Sciences.